Lamictal® has been found to have the potential for the serious side effects of severe, potentially life-threatening rash, including Stevens-Johnson syndrome and toxic-epidermal necrolysis.
Update: Lamictal Tied to Severe Immune System Reaction, FDA Warns
April 25, 2018 – Lamictal has been linked to a severe immune reaction called hemophagocytic lymphohistiocytosis (HLH), according to an FDA Safety Alert issued on Wednesday. As a result of this problem, FDA is requiring a new warning about HLH in the packaging of Lamictal.
What’s the problem?
The anticonvulsant drug Lamictal (lamotrigine) is marketed by GlaxoSmithKline, and is also available as a generic drug. It is used to treat the following disorders:
- partial epileptic seizures
- primary and secondary tonic-clonic seizures
- seizures associated with Lennox-Gastaut syndrome
- bipolar type I
Lamictal has been thought to have few side effects compared with other anticonvulsants, and treatment with it does not require blood monitoring in monotherapy (therapy in which only lamotrigine is used). But in September 2006, the US Food and Drug Administration (FDA) issued an alert pronouncing that new information suggested that babies exposed to Lamictal during the first three months of pregnancy may have a higher risk of being born with a cleft lip or palate. Babies with cleft lip or palate have a gap in the upper lip or roof of the mouth.
What other side effects can Lamictal cause?
Lamictal can cause many harmful and serious side effects, including:
- Stevens-Johnson Syndrome
- Toxic Epidermal Necrolysis (TEN)
- Life-threatening rashes (even more likely when Lamictal is combined with Depakene or Depakote medications)
- Disfigurement or death from rashes
- Mutli-organ failure
- Withdrawal seizures
- Sudden, unexplained death in epilepsy
Lamictal side effects have been added to the drug’s labeling in a boxed warning as of March 1997. Side effects were so serious that the FDA had the boxed warning added to include reports of severe, potentially life-threatening rash, including Stevens-Johnson syndrome and toxic epidermal necrolysis. In addition, prescription errors have occurred with Lamictal antiepileptic drug and Lamisil anti-fungal drug, greatly increasing the chances of suffering Lamictal side effects.
Do I have a Lamictal Lawsuit?
The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Lamictal lawsuits. We are handling individual litigation nationwide and currently accepting new SJS and TEN cases in all 50 states.
Free Case Evaluation: Again, if you or a loved one developed Stevens-Johnson syndrome or toxic epidermal nercolysis after taking Lamictal, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and we can help.